• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hempacco Announces Record Revenue for Fiscal Year 2022

    5/16/23 9:00:00 AM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email

    Hempacco files 10-K and reports record growth and expansion

    San Diego, California--(Newsfile Corp. - May 16, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, announced today that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2022, with the Securities and Exchange Commission. The company reported revenues of $3.967 million for the year ended December 31, 2022, an increase of 234% from $1.187 million for the year ended December 31, 2021.

    Hempacco attributed its strong performance to several factors, including:

    • The launch of its own hemp cigarette brand, The Real Stuff, gaining popularity among consumers looking for alternatives to tobacco and nicotine.
    • The expansion of celebrity partnership brands like Snoop Dogg, Cheech & Chong, and Hemp Hop with Rick Ross.
    • The introduction of HempBox, a company with six hundred kiosk vending machines that are planned to carry Hempacco's products.
    • The development of its proprietary technology and intellectual property used in the manufacturing of hemp paper and hemp cigarettes, plus its hemp filter infusion patent, a patent to spray hemp with terpenes, and the latest patent to take the cannabis smell out of hemp.
    • The establishment of its international presence, with the opening of its European office in Poland and the formation of a strategic alliance with Healthy Grains, the largest agricultural business exporter in Latin America.

    "We are very proud of our achievements in 2022, which reflect our vision to disrupt the tobacco industry with innovative hemp and CBD smokable products," said Sandro Piancone, co-founder and CEO of Hempacco. "We have established ourselves as a leader in this emerging market, with a diversified portfolio of brands, products, and services that cater to different segments and preferences of consumers. We have also invested in our technology, infrastructure, and partnerships to expand our reach and scale our operations globally. We are confident we have a strong foundation for continued growth in 2023 and beyond."

    Cannot view this image? Visit: https://images.newsfilecorp.com/files/8020/166253_hpco_files_10-k_550.jpg

    HPCO Files 10-K

    To view an enhanced version of this graphic, please visit:
    https://images.newsfilecorp.com/files/8020/166253_hpco_files_10-k.jpg

    Hempacco recently hired Growth Path Partners to help improve its periodic filing process. The decision was taken to ensure the company's financial statements were accurate and compliant with industry regulations. This move is expected to help Hempacco save time and money in the long run by streamlining the financial statement preparation and filing process and ensuring that the company's reports are reliable and prepared on a timely basis. The company anticipates that the pre-audit firm will also provide Hempacco with valuable insights into its financial performance, helping the company make sound decisions for the future.

    Hempacco became a publicly-traded Nasdaq company in 2022. The company saw the move as a sign of the industry's growing acceptance and popularity, as well as its potential for growth and profitability. Hempacco's decision to go public was met with enthusiasm from investors and cannabis enthusiasts alike. With its listing on a major stock exchange, Hempacco believes it has opened up investment opportunities for people interested in the industry. It has also created new use cases for hemp-derived products and services, which could potentially revolutionize the industry.

    About Hempacco
    Hempacco Co., Inc.'s goal is Disrupting Tobacco's™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand.

    Hempacco's operating segments include:

    1. Manufacturing of smokables, hemp rolling paper, and cannabinoid sticks
    2. Smokable technology development
    3. The Real Stuff™ brand of functional smokables and rolling paper
    4. Cheech and Chong Hemp Cigarettes and Hemp Hop Smokables with Rick Ross
    5. Snoop Dogg Joint Venture of Hemp-Derived Products

    Hempacco Co., Inc. is a publicly-traded Nasdaq company under the symbol HPCO. For more information about the company and its products, visit www.hempacco.com.

    For investor inquiries, please contact:

    Sandro Piancone, CEO
    Investor Relations: [email protected]
    619-779-0715

    Safe Harbor Statement

    This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the "S.E.C.") by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. 

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/166253

    Get the next $HPCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    SEC Filings

    View All

    Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Hempacco Co., Inc. (0001892480) (Filer)

    10/10/24 5:00:29 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Hempacco Co., Inc. (0001892480) (Filer)

    9/9/24 12:45:38 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Hempacco Co., Inc. (0001892480) (Filer)

    8/23/24 4:51:27 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hempacco Receives Notification of Deficiency from Nasdaq

    San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

    5/31/24 4:12:00 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

    NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

    5/6/24 9:30:00 AM ET
    $BNZI
    $HPCO
    $LRHC
    Computer Software: Prepackaged Software
    Technology
    Medicinal Chemicals and Botanical Products
    Health Care

    New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

    NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

    3/28/24 9:15:00 AM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Titus Stuart W

    4 - Hempacco Co., Inc. (0001892480) (Issuer)

    5/31/23 4:24:54 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

    3 - Hempacco Co., Inc. (0001892480) (Issuer)

    5/31/23 4:24:18 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    $HPCO
    Leadership Updates

    Live Leadership Updates

    View All

    Hempacco Announces Opening of European Office as Part of International Expansion Strategy

    Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

    4/4/23 9:00:00 AM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care